Literature DB >> 18506850

Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells.

Elisa Alchera1, Lorenza Tacchini, Chiara Imarisio, Caterina Dal Ponte, Cristina De Ponti, Elena Gammella, Gaetano Cairo, Emanuele Albano, Rita Carini.   

Abstract

UNLABELLED: The cellular mechanisms by which ischemic preconditioning increases liver tolerance to ischemia/reperfusion injury are still poorly understood. This study investigated the role of the hypoxia-inducible factor-1 (HIF-1) in the protection associated with the late phase of liver preconditioning. Late preconditioning was induced in primary cultured rat hepatocytes by a transient (10 minute) hypoxic stress or by 15 minutes incubation with the adenosine A(2A) receptors agonist CGS21680 24 hours before exposure to 90 minutes of hypoxia in a serum-free medium. Late preconditioning induced the nuclear translocation of HIF-1 and the expression of carbonic anhydrase IX (CAIX), a HIF-1-regulated transmembrane enzyme that catalyzes bicarbonate production. Such effects were associated with prevention of hepatocyte killing by hypoxia and the amelioration of intracellular acidosis and Na+ accumulation. The inhibition of PKC-mediated and PI3-kinase-mediated signals with, respectively, chelerythrine and wortmannin abolished HIF-1 activation and blocked both CAIX expression and the protective action of late preconditioning. CAIX expression was also prevented by interfering with the transcriptional activity of HIF-1 using a dominant negative HIF-1beta subunit. The inhibition of CAIX with acetazolamide or the block of bicarbonate influx with disodium-4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate also reverted the protective effects of late preconditioning on intracellular acidosis and Na+ accumulation.
CONCLUSION: The stimulation of adenosine A(2A) receptors induced late preconditioning in liver cells through the activation of HIF-1. HIF-1-induced expression of CAIX increases hepatocyte tolerance to ischemia by maintaining intracellular Na+ homeostasis. These observations along with the importance of HIF-1 in regulating cell survival indicates HIF-1 activation as a possible key event in liver protection by late preconditioning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506850     DOI: 10.1002/hep.22249

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 3.  Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.

Authors:  Bharath Nath; Gyongyi Szabo
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 4.  Targeting iNKT cells for the treatment of sickle cell disease.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Clin Immunol       Date:  2011-03-22       Impact factor: 3.969

Review 5.  Ischemia/reperfusion injury in liver resection: a review of preconditioning methods.

Authors:  Kassiani Theodoraki; Aliki Tympa; Iosifina Karmaniolou; Athanassia Tsaroucha; Nikolaos Arkadopoulos; Vassilios Smyrniotis
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

Review 6.  Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.

Authors:  Ling Lu; Haoming Zhou; Ming Ni; Xuehao Wang; Ronald Busuttil; Jerzy Kupiec-Weglinski; Yuan Zhai
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

Review 7.  Regulation of leukocyte function by adenosine receptors.

Authors:  Joel Linden
Journal:  Adv Pharmacol       Date:  2011

Review 8.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

9.  Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production.

Authors:  Sergey Ryzhov; Asel Biktasova; Anna E Goldstein; Qinkun Zhang; Italo Biaggioni; Mikhail M Dikov; Igor Feoktistov
Journal:  Mol Pharmacol       Date:  2013-10-17       Impact factor: 4.436

Review 10.  Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease.

Authors:  Peter Fraisl; Julián Aragonés; Peter Carmeliet
Journal:  Nat Rev Drug Discov       Date:  2009-01-23       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.